TY  - GEN
AU  - Thomas,Deborah A
AU  - Faderl,Stefan
AU  - O'Brien,Susan
AU  - Bueso-Ramos,Carlos
AU  - Cortes,Jorge
AU  - Garcia-Manero,Guillermo
AU  - Giles,Francis J
AU  - Verstovsek,Srdan
AU  - Wierda,William G
AU  - Pierce,Sherry A
AU  - Shan,Jianqin
AU  - Brandt,Mark
AU  - Hagemeister,Fredrick B
AU  - Keating,Michael J
AU  - Cabanillas,Fernando
AU  - Kantarjian,Hagop
TI  - Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia
SN  - 0008-543X
PY  - 2006///0425
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Burkitt Lymphoma
KW  - drug therapy
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Dexamethasone
KW  - Doxorubicin
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Immunotherapy
KW  - Infusions, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Rituximab
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1002/cncr.21776
ER  -